This text is a result of machine translation.
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Yongmaotai: the net profit in the first half of the year was 122 million yuan, a year-on-year increase of 76%
Mindray, the Dominant A-share Medical Device Maker: Not a COVID-19 Speculator
Mindray Medical (300760:SH) is the most expensive stock in the segment of Chinese medical devices so far. Now this giant is following the domestic healthcare reform and raising the high-tech tide with organic growth.
Jun 24, 2020 11:42 AM
Northbound capital increased its position by 26 shares for 7 consecutive weeks
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
In the second quarter, the public fund's heavy position stocks are released, and Guizhou Maotai is still the largest heavy position stocks